(Q33988155)

30 July 2017

0 references

Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature (English)

1 reference

30 July 2017

main subject

anti-retroviral agent

0 references

0 references

Louise C Ivers

0 references

Karen Doucette

0 references

David Kendrick

1 reference

30 July 2017

language of work or name

English

0 references

publication date

27 May 2005

1 reference

Clinical Infectious Diseases

30 July 2017

published in

1 reference

30 July 2017

1 reference

30 July 2017

1 reference

30 July 2017

page(s)

217-224

1 reference

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

30 July 2017

cites work

1 reference

Tackling HIV in resource poor countries

21 January 2018

1 reference

Defining and refining international donor support for combating the AIDS pandemic

21 January 2018

1 reference

Global plagues and the Global Fund: Challenges in the fight against HIV, TB and malaria

21 January 2018

1 reference

Preventing antiretroviral anarchy in sub-Saharan Africa

21 January 2018

1 reference

Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance

21 January 2018

1 reference

The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study

21 January 2018

1 reference

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

21 January 2018

1 reference

Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting

21 January 2018

1 reference

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial

21 January 2018

1 reference

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

21 January 2018

1 reference

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome

21 January 2018

1 reference

Virological response to protease inhibitor therapy in an HIV clinic cohort.

21 January 2018

1 reference

Adherence is not a barrier to successful antiretroviral therapy in South Africa

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/431199

1 reference

30 July 2017

1 reference